13.12.2013 15:08:53
|
FMC Corp. To Sell Peroxygens Business To One Equity Partners For $200 Mln
(RTTNews) - Diversified chemicals maker FMC Corp. (FMC) said Friday that it has signed a definitive agreement to sell its Peroxygens business to affiliates of One Equity Partners, the private investment arm of J.P. Morgan Chase & Co. (JPM). The transaction valued at approximately $200 million.
It is expected to close in the first quarter of 2014, subject to customary regulatory approvals and closing conditions.
In April, FMC simplified its organizational structure to focus on three core business segments that better reflect the markets where the company participates and leads, and where it expects to grow in the future. FMC Peroxygens, although a successful business, is not a strategic fit with the company's growth platforms.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu JPMorgan Chase & Co.mehr Nachrichten
Analysen zu JPMorgan Chase & Co.mehr Analysen
16.01.25 | JPMorgan Chase Outperform | RBC Capital Markets | |
16.01.25 | JPMorgan Chase Halten | DZ BANK | |
16.01.25 | JPMorgan Chase Buy | UBS AG | |
15.01.25 | JPMorgan Chase Outperform | RBC Capital Markets | |
02.12.24 | JPMorgan Chase Hold | Deutsche Bank AG |
Aktien in diesem Artikel
FMC Corp. | 53,60 | -0,96% | |
JPMorgan Chase & Co. | 257,80 | 0,12% |